EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

bFGF rescues dysfunctional properties of adipose-derived stem cells from individuals with type 2 diabetes by modulating their miRNA profile

Anna Civit-Urgell, Esther Peña, Maria Teresa Bejar, Fabrizio Moscatiello, Gemma Vilahur, Lina Badimon, Gemma Arderiu

Diabetologia · 2025

DOI: 10.1007/s00125-025-06533-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologia, 2025. Verfasst von Anna Civit-Urgell und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, MicroRNAs, Fibroblast Growth Factor 2, Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya, Dirección Nacional de Innovación, Ciencia y Tecnología, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis The aim of this study was to investigate whether basic fibroblast growth factor (bFGF) can restore the proliferation and migration capacities of adipose-derived stem cells (ASCs), which are impaired by type 2 diabetes, and improve vascular remodelling. Methods ASCs obtained from individuals with or without diabetes were cultured with 10 ng/ml bFGF for 9 days. The ASCs were phenotypically characterised and functionally tested for proliferation capacity. Differentially expressed miRNAs before and after treatment were analysed using miRNA arrays. Crosstalk between ASCs and human vascular smooth muscle cells (HVSMCs) was assessed using wound healing, transwell migration and co-culture assays. Finally, a Matrigel plug assay in nude mice was used to evaluate the contribution of ASCs to neovessel formation. Results bFGF treatment significantly enhanced the proliferation and migration of ASCs from individuals with type 2 diabetes (T2DM ASCs), and altered the expression of miRNAs associated with ASC proliferation. ASCs promoted HVSMC migration and, when co-cultured, facilitated tube-like structure formation. In vivo Matrigel plug assays revealed that bFGF treatment enhanced neovessel formation. Although both non-T2DM ASCs (ASCs from individuals without type 2 diabetes) and untreated T2DM ASCs stimulated angiogenesis, bFGF-treated subcutaneous and visceral T2DM ASCs promoted even greater neovessel formation. Additionally, bFGF treatment modulated the expression of multiple angiogenesis-related miRNAs in ASCs. Conclusions/interpretation Preconditioning T2DM ASCs with bFGF alters their miRNA profile, enhancing cell proliferation and their vascular remodelling potential. This strategy could improve the therapeutic utility of T2DM ASCs. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2MicroRNAsFibroblast Growth Factor 2Stem CellsAdipose TissueHumansAnimalsCell ProliferationCell MovementMiceMice, NudeMiddle AgedMaleCells, CulturedFemaleCoculture Techniques

Stichwörter der Autor:innen

ASCsAngiogenesisEndothelial cellsMicroRNAsType 2 diabetesbFGF

Substanzen

MicroRNAsFibroblast Growth Factor 2

Autor:innen und Institutionen

  • Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain.
  • Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona (UB), Barcelona, Spain.
  • Centro de Investigación Biomédica en Red Cardiovascular (CIBER CV), Instituto de Salud Carlos III, Madrid, Spain.
  • Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Clínica Teknon, Grupo Quiron Salut, Barcelona, Spain.
  • School of Medicine, Universitat de Vic-UCC and Cardiovascular Research Foundation for Health Prevention and Innovation (FICSI), Barcelona, Spain.

Förderung

  • Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya
  • Dirección Nacional de Innovación, Ciencia y Tecnología
  • Instituto de Salud Carlos III
  • Fundació Institució dels Centres de Recerca de Catalunya

Zitieren

APA

Civit-Urgell, A., Peña, E., Bejar, M. T., Moscatiello, F., Vilahur, G., Badimon, L., & Arderiu, G. (2025). bFGF rescues dysfunctional properties of adipose-derived stem cells from individuals with type 2 diabetes by modulating their miRNA profile. Diabetologia. https://doi.org/10.1007/s00125-025-06533-0

Vancouver

Civit-Urgell A, Peña E, Bejar MT, Moscatiello F, Vilahur G, Badimon L, et al. bFGF rescues dysfunctional properties of adipose-derived stem cells from individuals with type 2 diabetes by modulating their miRNA profile. Diabetologia. 2025. doi:10.1007/s00125-025-06533-0

BibTeX
@article{CivitUrgell2025,
  author = {Civit-Urgell, Anna and Peña, Esther and Bejar, Maria Teresa and Moscatiello, Fabrizio and Vilahur, Gemma and Badimon, Lina and Arderiu, Gemma},
  title = {bFGF rescues dysfunctional properties of adipose-derived stem cells from individuals with type 2 diabetes by modulating their miRNA profile},
  journal = {Diabetologia},
  year = {2025},
  doi = {10.1007/s00125-025-06533-0}
}
Kostenlos starten →